Current through Register Vol. XLI, No. 25, June 21, 2024
Section 11-6-2 - [Effective until 7/1/2024] DefinitionsDefinitions set forth in 11 CSR 1A are hereby incorporated by reference.
2.1. "ABMS" means American Board of Medical Specialties.2.2. "Board" means the West Virginia Board of Medicine.2.3. "Chronic pain" means pain that has persisted after reasonable medical efforts have been made to relieve the pain or cure its cause and that has continued, either continuously or episodically, for longer than three (3) continuous months. For purposes of this rule, "chronic pain" does not include pain associated with a terminal condition or illness or with a progressive disease that, in the normal course of progression, may reasonably be expected to result in a terminal condition or illness.2.4. "Controlled substances" means drugs that are classified by federal or state law in Schedules I, II, III, IV or V, as defined in W. Va. Code § 60A-2-204 through 212.2.5. "Drug diversion training and best practice prescribing of controlled substances training" means training which includes all of the following: 2.5.a. Drug diversion, including West Virginia statistics on prescription drug abuse and resulting deaths.2.5.b. Epidemiology of chronic pain and misuse of opioids.2.5.c. Indication for opioids in chronic pain treatment including general characteristics, toxicities and drug interactions.2.5.d. Examination of patient evaluation and risk assessment and tools to assess risk and monitor benefits.2.5.e. Initiation and ongoing management of chronic pain patients treated with opioid based therapies, including treatment objectives; monitoring and periodic review; referrals and consultations; informed consent; prescription of controlled substance agreements, urine screens and pill counts; patient education on safe use, storage and disposal of opioids; discontinuation of opioids for pain due to lack of benefits or increased risks; documentation and medical records.2.5.f. Case study of a patient with chronic pain.2.5.g. Identification of diversion and drug seeking tactics and behaviors.2.5.h. Best practice methods for working with patients suspected of drug seeking behavior and diversion.2.5.i. Compliance with controlled substances laws and rules.2.5.j. Training on prescribing and administration of an opioid antagonist.2.5.k. Training on the impacts of stigma on treatment effectiveness including the concept of addiction as a chronic disease;2.5.l. Introduction to Medication for Opioid Use Disorder (MOUD) and training on the effectiveness of MOUD treatment including the use of full opioid agonist, partial opioid agonist, and opioid antagonists;2.5.m. Registration with and use of the West Virginia Controlled Substances Monitoring Program established in West Virginia Code Chapter 60A, Article 9.2.5.n. Information related to substance use disorder treatment referral, including but not limited to programs and initiatives developed through the Governor's Council on Substance Abuse Prevention and Treatment, the Governor's Committee on Crime, Delinquency, and Correction, and/or W. Va. Code § 15-9-7.2.5.o. Maintenance of a record of attendance of each individual who successfully completes the drug diversion training and best practice prescribing of controlled substances training.2.6. "Licensee" means a physician or podiatric physician licensed pursuant to the provisions of W. Va. Code § 30 -3-1 et seq. and the provisions of 11 CSR 1A.2.7. "Maintenance of certification" means an ongoing process of education and assessment for the twenty four member boards of the ABMS board certified physicians to improve practice performance in six core competencies: professionalism, patient care and professional skills, medical knowledge, practice based learning and improvement, interpersonal and communication skills, and systems based practice.2.8. "Opioid" means natural and semi-synthetic derivatives of the opium poppy, as well as similar synthetic compounds that have analgesic or pain relieving properties because of their effects in the central nervous system. These include, but are not limited to, codeine, morphine, hydromorphone, hydrocodone, oxycodone, methadone, and fentanyl.2.9. "Reactivation" means re-licensure of an eligible former licensee who has not held a license issued by the Board for more than one year immediately preceding the request for reactivation.2.10. "Reinstatement" means re-licensure of an eligible former licensee whose license automatically expired or was subject to a non-disciplinary voluntary surrender less than one year prior to the request for reinstatement.2.11. "Renewal applicant" means a licensee who is seeking to renew a license issued by the Board.2.12. "Reporting period" means the two-year period preceding the renewal deadline for a license issued by the Board. Continuing education satisfactory to the Board must be obtained in each reporting period.2.13. "Website" or "Board's website" means the set of related web pages operated by or on behalf of the West Virginia Board of Medicine located at the domain name wvbom.wv.gov, or at any successor domain name published by the Board.